1,691 results
Search Results
52. Speech, language and communication needs and mental health: the experiences of speech and language therapists and mental health professionals.
- Author
-
Hancock, Annabel, Northcott, Sarah, Hobson, Hannah, and Clarke, Michael
- Subjects
- *
MENTAL illness treatment , *TREATMENT of learning disabilities , *TREATMENT of language disorders , *ANXIETY treatment , *TREATMENT of autism , *WELL-being , *GRIEF , *THERAPEUTICS , *COUNSELING , *DEGLUTITION , *ATTITUDES of medical personnel , *WORK , *MENTAL health , *PSYCHOLOGISTS , *INTERVIEWING , *LANGUAGE & languages , *COGNITION , *QUALITATIVE research , *EXPERIENTIAL learning , *SOUND recordings , *NEEDS assessment , *PLAY therapy , *THEMATIC analysis , *EMOTIONS , *REFLEXIVITY , *SPEECH therapists , *MENTAL health services , *BEREAVEMENT , *VIDEO recording - Abstract
Background: While the relationship between speech, language and communication needs (SLCN) and mental health difficulties has been recognized, speech and language therapists (SLTs), and mental health professionals face challenges in assessing and treating children with these co‐occurring needs. There exists a gap in the evidence base for best practice for professionals working with children and young people (CYP) who experience difficulties in both areas. Aims: To explore the views of SLTs and mental health clinicians about their experiences of working with CYP exhibiting co‐occurring SLCN and mental health difficulties. Methods & Procedures: Semi‐structured interviews were conducted with eight SLTs and six mental health professionals, including psychotherapists, clinical psychologists, play therapists and counsellors, with experience working with CYP with SLCN. Interviews were analysed using reflexive thematic analysis and themes were identified from the data. Outcomes & Results: Participants felt that SLCN and mental health difficulties frequently co‐occur. Participants described how CYP with SLCN and mental health issues commonly experience difficulties across and between the domains of language and cognition, emotional well‐being and challenging behaviour. Findings suggest that there are organizational limitations in the fields of SLT and mental health that have implications for the efficacy of assessment and treatment of CYP with SLCN and mental health difficulties. Traditional talking therapies were perceived to be inaccessible and ineffective for CYP with SLCN and mental health difficulties. Interventions blending behaviour and emotion programmes with language and communication interventions were considered potentially beneficial. Conclusions & Implications: Future research should explore and evaluate current services and service set‐up in SLT and mental health. The findings from this study have important implications for the efficacy of treatments provided to this population suggesting that more research needs to be done into effective diagnosis and interventions for this population. WHAT THIS PAPER ADDS: What is already known on the subject: Research suggests that CYP with SLCN, such as developmental language disorder (DLD), are likely to experience mental health difficulties including depression, anxiety and poor emotional well‐being. CYP who experience difficulties with SLCN and poor mental health are not well understood and this area remains under‐researched. This has implications for clinician knowledge and therefore the effective diagnosis and treatment of children and adolescents experiencing SLCN and mental health difficulties. In addition, little is known about the accessibility of talking therapies to CYP presenting with SLCN and mental health difficulties. What this paper adds to existing knowledge: SLCN issues are understood by SLTs and mental health issues are understood by mental health professionals, but where these co‐occur difficulties exist for the diagnostic process, with professionals perceiving that CYP in this category are often undiagnosed or misdiagnosed. Organizational boundaries between SLT and mental health were perceived to contribute to a lack of understanding of SLCN and mental health needs, which has implications for effective diagnosis and treatment. Traditional talking therapies were thought to be inaccessible for CYP with SLCN and mental health difficulties. Interventions used in both SLT and psychotherapy were perceived as clinically useful if combined. What are the potential or actual clinical implications of this work?: This paper highlights implications for the accessibility and efficacy of the assessment and treatment provided to this population and to the organization of services currently treating this group of CYP. A direction for future research would be to undertake service evaluations and intervention‐based studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
53. Intrusiveness of illness and quality of life in young women with breast cancer<FNR></FNR><FN>An earlier version of the paper was presented at the ESPO 9 in Amsterdam, The Netherlands, July 9, 1996, and at a Womens Health Conference, APA, Washington, DC, USA, September 20, 1996. The efforts of Merrilee Morrow are gratefully acknowledged as well as the National Cancer Institute for their financial support. </FN>
- Author
-
Bloom, Joan R., Stewart, Susan L., Johnston, Monica, and Bank, Priscilla
- Subjects
- *
BREAST cancer , *QUALITY of life , *YOUNG women , *THERAPEUTICS , *HEALTH - Abstract
Our objective was to test a theoretical model that explains quality of life as a function of the intrusiveness of illness encroaching on the different domains of one’s life. The intrusiveness of illness is explained not only by disease and treatment related factors, but also by one’s psychological and social resources (Devins, 1994). To investigate this issue, a sample of 336 women aged 50 and under, recently diagnosed with breast cancer were interviewed in their homes. Consistent with Devins’ model, intrusiveness of illness mediated the effect of disease and treatment factors on quality of life. Contrary to his model, some treatment factors also had direct effects while social and psychological factors had only direct effects on quality of life. Neither time post-diagnosis nor type of treatment affected the psychological component of quality of life. © 1998 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
54. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
TREATMENT of horse diseases , *HORSE diseases , *MYCOSES , *MUSCLE disease treatment , *FALLOPIAN tube radiography , *DISEASE risk factors , *THERAPEUTICS - Abstract
The article discusses the role of salpingopharyngostomy in treating certain cases of guttural pouch mycosis in horses. Topics discussed include treatment of fibrotic myopathy; tenotomy of the semitendinosus muscle in horses with fibrotic myopathy; and the issues relating to the Inflammatory disease.
- Published
- 2018
- Full Text
- View/download PDF
55. Factors influencing decisions people with motor neuron disease make about gastrostomy placement and ventilation: A qualitative evidence synthesis.
- Author
-
White, Sean, O'Cathain, Alicia, Halliday, Vanessa, Croot, Liz, and McDermott, Christopher J.
- Subjects
- *
THERAPEUTICS , *PSYCHOLOGY information storage & retrieval systems , *CINAHL database , *PATIENT autonomy , *MEDICAL information storage & retrieval systems , *PATIENT decision making , *ATTITUDE (Psychology) , *MOTOR neuron diseases , *BIBLIOGRAPHY , *ARTIFICIAL respiration , *PATIENTS' attitudes , *QUALITATIVE research , *QUALITY of life , *AMYOTROPHIC lateral sclerosis , *QUALITY assurance , *RESEARCH funding , *GASTROSTOMY , *THEMATIC analysis , *MEDLINE , *CORPORATE culture - Abstract
Background: People with motor neuron disease (pwMND) are routinely offered gastrostomy feeding tube placement and (non‐invasive and invasive) ventilation to manage the functional decline associated with the disease. This study aimed to synthesise the findings from the qualitative literature to understand how individual, clinical team and organisational factors influence pwMND decisions about these interventions. Methods: The study design was guided by the enhancing transparency in reporting the synthesis of qualitative research (ENTREC) statement. The search of five bibliography databases and an extensive supplementary search strategy identified 27 papers that included qualitative accounts of pwMND, caregivers and healthcare professionals' (HCPs) experiences of making decisions about gastrostomy and ventilation. The findings from each study were included in a thematic synthesis. Findings: Making decisions about interventions is an emotional rather than simply a functional issue for pwMND. The interventions can signal an end to normality, and increasing dependence, where pwMND consider the balance between quality of life and extending survival. Interactions with multiple HCPs and caregivers can influence the process of decision‐making and the decisions made. These interactions contribute to the autonomy pwMND are able to exert during decision‐making. HCPs can both promote and threaten pwMND perceived agency over decisions through how they approach discussions about these interventions. Though there is uncertainty over the timing of interventions, pwMND who agree to interventions report reaching a tipping point where they accept the need for change. Conclusion: Discussion of gastrostomy and ventilation options generate an emotional response in pwMND. Decisions are the consequence of interactions with multiple external agents, including HCPs treading a complex ethical path when trying to improve health outcomes while respecting pwMND right to autonomy. Future decision support interventions that address the emotional response and seek to support autonomy have the potential to enable pwMND to make informed and timely decisions about gastrostomy placement and ventilation. Patient or Public Contribution: The lead author collaborated with several patient and participant involvement (PPI) groups with regards to the conceptualisation and design of this project. Decisions that have been influenced by discussions with multiple PPI panels include widening the scope of decisions about ventilation in addition to gastrostomy placement and the perceptions of all stakeholders involved (i.e., pwMND, caregivers and HCPs). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
56. How do patients feel during the first 72 h after initiating long‐acting injectable buprenorphine? An embodied qualitative analysis.
- Author
-
Neale, Joanne, Parkin, Stephen, and Strang, John
- Subjects
- *
THERAPEUTICS , *SLEEP quality , *DRUG efficacy , *SUBSTANCE abuse , *INJECTIONS , *PAIN , *BUPRENORPHINE , *ATTITUDE (Psychology) , *RESEARCH methodology , *INTERVIEWING , *DRUG withdrawal symptoms , *PATIENTS' attitudes , *QUALITATIVE research , *COMPARATIVE studies , *CONTROLLED release preparations , *SOUND recordings , *SLEEP deprivation , *DESCRIPTIVE statistics , *DRUGS , *QUALITY of life , *RESEARCH funding , *OPIOID analgesics , *PATIENT compliance , *EVALUATION - Abstract
Background and Aims: Long‐acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that is generating positive outcomes. Negative effects are typically mild and transient, but can occasionally be serious, resulting in treatment discontinuation/non‐adherence. This paper aims to analyse patients' accounts of how they felt during the first 72 h after initiating LAIB. Methods: Semi‐structured interviews were conducted (June 2021–March 2022) with 26 people (18 males and 8 females) who had started LAIB within the previous 72 h. Participants were recruited from treatment services in England and Wales and were interviewed by telephone using a topic guide. Interviews were audio‐recorded, transcribed and coded. The concepts of embodiment and embodied cognition framed the analyses. Data on participants' substance use, initiation onto LAIB and feelings were tabulated. Next, participants' accounts of how they felt were analysed following the stages of Iterative Categorization. Results: Participants reported complex combinations of changing negative and positive feelings. Bodily experiences included withdrawal symptoms, poor sleep, injection‐site pain/soreness, lethargy and heightened senses inducing nausea ('distressed bodies'), but also enhanced somatic wellbeing, improved sleep, better skin, increased appetite, reduced constipation and heightened senses inducing pleasure ('returning body functions'). Cognitive responses included anxiety, uncertainties and low mood/depression ('the mind in crisis') and improved mood, greater positivity and reduced craving ('feeling psychologically better'). Whereas most negative effects reported are widely recognized, the early benefits of treatment described are less well‐documented and may be an overlooked distinctive feature of LAIB. Conclusions: During the first 72 h after initiating long‐acting injectable buprenorphine, new patients report experiencing a range of interconnected positive and negative short‐term effects. Providing new patients with information about the range and nature of these effects can prepare them for what to expect and help them manage feelings and reduce anxiety. In turn, this may increase medication adherence. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
57. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.
- Author
-
Sköld, C. M., Bendstrup, E., Myllärniemi, M., Gudmundsson, G., Sjåheim, T., Hilberg, O., Altraja, A., Kaarteenaho, R., and Ferrara, G.
- Subjects
- *
IDIOPATHIC pulmonary fibrosis , *LUNG transplantation , *MEDICAL rehabilitation , *PALLIATIVE treatment , *DRUG therapy , *THERAPEUTICS , *ALGORITHMS , *NONSTEROIDAL anti-inflammatory agents , *PYRIDINE , *DISEASE complications , *INDOLE compounds - Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal progressive lung disease occurring in adults. In the last decade, the results of a number of clinical trials based on the updated disease classification have been published. The registration of pirfenidone and nintedanib, the first two pharmacological treatment options approved for IPF, marks a new chapter in the management of patients with this disease. Other nonpharmacological treatments such as lung transplantation, rehabilitation and palliation have also been shown to be beneficial for these patients. In this review, past and present management is discussed based on a comprehensive literature search. A treatment algorithm is presented based on available evidence and our overall clinical experience. In addition, unmet needs with regard to treatment are highlighted and discussed. We describe the development of various treatment options for IPF from the first consensus to recent guidelines based on evidence from large-scale, multinational, randomized clinical trials, which have led to registration of the first drugs for IPF. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
58. Short Papers Meeting, Royal Society of Medicine, London, Section of Coloproctology, 24 November 1999.
- Author
-
Bhardwaj, R., Craggs, M.D., Vaizey, C.J., and Boulus, P.B.
- Subjects
- *
ANAL diseases , *ADRENERGIC beta agonists , *ADRENERGIC alpha blockers , *THERAPEUTICS - Abstract
Background Internal anal sphincter tone depends on the intrinsic myogenic properties of smooth muscle and external neural influences, specifically a continuous sympathetic input. Reduction of maximum resting anal canal pressure (MRP) increases the vascularity of ischaemic chronic anal fissures and promotes healing. Methods Ten patients with chronic anal fissures (median age 35.5 (28-65) years) and 10 healthy volunteers (median age 28 (21-38) years) were administered 20 mg indoramin (α[sub 1]-antagonist) or 4 mg salbutamol (&beta[sub 2]-agonist) orally in a doubleblinded manner. MRP, pulse, and blood pressure were measured prior to and at hourly intervals until 3 h after administration. Results Patients with chronic anal fissures had a significantly higher MRP compared with volunteers (P < 0.05, MannWhitney U-test). In each group there was a significant reduction in MRP at 1, 2 and 3 h (P < 0.05, Wilcoxon signed ranks test). Indoramin and salbutamol demonstrated no significant difference in effect when comparing reduction of MRP in patients and volunteers (Mann-Whitney U-test). The reduction in patients' MRP at 3 h was comparable to that after lateral sphincterotomy. Tremors were noted with salbutamol in four volunteers, and five patients. Three patients complained of light-headedness with indoramin without a significant change in diastolic blood pressure. The reduction in MRP in subjects who took indoramin did not correlate with a reduction in diastolic blood pressure (Pearson correlation coefficient, r = 0. 166, P = NS). Conclusion Oral indoramin causes a sustained reduction in MRP, without serious side effects, and may have a beneficial role in the treatment of anal fissures. (MRP - maximum resting anal canal pressure). [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
59. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
VETERINARY medicine , *FUROSEMIDE , *RACE horses , *ARTERIOVENOUS anastomosis , *QUARTER horse , *DISEASES , *THERAPEUTICS - Abstract
The article offers information on several studies related to equine veterinary. Topics discussed include efficacy of furosemide dosing regimens in the reduction of exercise-induced pulmonary haemorrhage (EIPH) severity in racehorses; complications in horses undergoing large colon resection with either sutured end-to-end or stapled functional end-to-end anastomoses; and potential associations between repository radiographic findings and subsequent performance of Quarter Horses.
- Published
- 2018
- Full Text
- View/download PDF
60. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
MOXIDECTIN , *IVERMECTIN , *NERVOUS system abnormalities , *BRONCHOPNEUMONIA , *TULATHROMYCIN , *THERAPEUTICS - Abstract
Reviews of several articles related to prevalence of headshaking, efficacy of ivermectin (IVE) and moxidectin (MOX) on faecal egg counts, and bronchopneumonia treatment with tulathromycin which appeared in the previous issue of the periodical, were presented.
- Published
- 2017
- Full Text
- View/download PDF
61. Medicalising the menace? The symbiotic convergence of medicine and law enforcement in the medicalisation of marijuana in Minnesota.
- Subjects
- *
PROFESSIONAL ethics , *CLINICAL governance , *HEALTH services administration , *REGULATORY approval , *DRUG laws , *SOCIAL boundaries , *MEDICAL marijuana , *DISCOURSE analysis , *THERAPEUTICS - Abstract
The medicalisation of marijuana has occurred rapidly, albeit nonuniformly, across the US and around the world over the past 3 decades. This paper centres on the medicalisation of marijuana in Minnesota—which has one of the most restrictive programs in the country—as a case for evaluating the negotiation of institutional boundaries with the shift from criminalisation to medicalisation after nearly a century of criminal prohibition. Drawing upon Foucauldian discourse analyses of the medical and law enforcement associations' position statements and legislative hearings that shaped medical marijuana policy in Minnesota, this paper demonstrates a symbiotic convergence between medicine and law enforcement through the deployment of shared discursive strategies in their opposition to medical marijuana that reinforce marijuana's criminalised status by solidifying the boundaries between proper medicine and dangerous drugs. Criminal justice and medical institutions draw upon one another's definitions, logics, and practices in a mutually constitutive manner, while still maintaining distinct user subjects and institutional interventions for each based on the user's access to state‐approved forms of marijuana. The consequences for the governing of marijuana in Minnesota are explored, as well as the broader implications for the sociological study of medicalisation and criminalisation with respect to the governance of drugs and health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
62. Managing ongoing swallow safety through information‐sharing: An ethnography of speech and language therapists and nurses at work on stroke units.
- Author
-
Barnard, Rachel, Jones, Julia, and Cruice, Madeline
- Subjects
- *
THERAPEUTICS , *OCCUPATIONAL roles , *FIELD research , *STROKE , *DEGLUTITION , *NURSES' attitudes , *ATTITUDES of medical personnel , *RESEARCH methodology , *DEGLUTITION disorders , *INTERVIEWING , *ETHNOLOGY research , *INTERPROFESSIONAL relations , *COMMUNICATION , *NURSES , *HOSPITAL nursing staff , *RESEARCH funding , *FIELD notes (Science) , *DATA analysis , *SPEECH therapists , *PATIENT safety , *DISEASE complications - Abstract
Background: Speech and language therapists and nurses need to work together to keep patients with swallowing difficulties safe throughout their acute stroke admission. Speech and language therapists make recommendations for safe swallowing following assessment and nurses put recommendations into practice and monitor how patients cope. There has been little research into the everyday realities of ongoing swallow safety management by these two disciplines. Patient safety research in other fields of healthcare indicates that safety can be enhanced through understanding the cultural context in which risk decisions are made. Aims: To generate new understanding for how speech and language therapists (SLTs) and nurses share information for ongoing management of swallows safety on stroke units. Methods & Procedures: An ethnographic methodology involving 40 weeks of fieldwork on three stroke wards in England between 2015 and 2017. Fieldwork observation (357 h) and interviews with 43 members of SLT and nursing staff. Observational and interview data were analysed iteratively using techniques from the constant comparative method to create a thematically organized explanation. Outcomes & Results: An explanation for how disciplinary differences in time and space influenced how SLT and nursing staff shared information for ongoing management of swallow safety, based around three themes: (1) SLTs and nurses were aligned in concern for swallow safety across all information‐sharing routes; however, (2) ambiguity was introduced by the need for the information contained in swallowing recommendations to travel across time, creating dilemmas for nurses. Patients could improve or deteriorate after recommendations were made and nurses had competing demands on their time. Ambiguity had consequences for (3) critical incident reporting and relationships. SLTs experienced dilemmas over how to act when recommendations were not followed. Conclusions & Implications: This study provides new understanding for patient safety dilemmas associated with the enactment and oversight of swallowing recommendations in context, on stroke wards. Findings can support SLTs and nurses to explore together how information for ongoing dysphagia management can be safely implemented within ward realities and kept up to date. This could include considering nursing capacity to act when SLTs are not there, mealtime staffing and SLT 7‐day working. Together they can review their understanding of risk and preferred local and formal routes for learning from it. What this paper adds: What is already known on the subject: It is known that information to keep swallowing safe is shared through swallowing recommendations, which are understood to involve a balance of risks between optimizing the safety of the swallow mechanism and maintaining physiological and emotional health. There is increasing appreciation from patient safety research, of the importance of understanding the context in which hospital staff make decisions about risk and patient safety. What this paper adds to existing knowledge: The paper provides new empirical understanding for the complexities of risk management associated with SLT and nursing interactions and roles with respect to ongoing swallow safety. What are the potential or actual clinical implications of this work?: Findings can underpin SLT and nurse discussion about how swallow safety could be improved in their own settings. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
63. Understanding treatment non‐responders: A qualitative study of depressed adolescents' experiences of 'unsuccessful' psychotherapy.
- Author
-
Mehta, Alisha, Dykiert, Dominika, and Midgley, Nick
- Subjects
- *
THERAPEUTICS , *ATTITUDE (Psychology) , *INTERVIEWING , *TREATMENT effectiveness , *QUALITATIVE research , *PHENOMENOLOGY , *PRE-tests & post-tests , *MENTAL depression , *JUDGMENT sampling , *PSYCHOTHERAPY , *THERAPEUTIC alliance , *PSYCHOSOCIAL factors , *ADOLESCENCE - Abstract
Objectives: This paper aimed to explore the experiences of depressed adolescents who completed but did not 'respond' to standard psychotherapy, based on a lack of improvement in pre‐post symptoms scores. Design: This was a qualitative study employing interpretative phenomenological analysis (IPA). Method: Seventy‐seven adolescents with moderate to severe depression were interviewed as part of a qualitative arm of a randomised controlled trial. Five adolescents' post‐treatment interviews were purposively sampled, based on lack of improvement on pre‐post symptom scores, and adolescents still scoring above the clinical threshold for depression. The interviews were analysed using IPA. Results: Adolescents made sense of their depression as part of their identity and held negative expectations of therapy. Some aspects of therapy brought up intolerable feelings that contributed to disengagement in the therapeutic process and culminated in disappointing and hopeless endings. On the other hand, where a stronger therapeutic relationship was developed, some participants experienced certain improvements. Conclusions: Findings highlight how actively exploring the adolescent's therapy expectations, developing a strong early therapeutic relationship and being mindful of the potential impact of endings are important in therapeutic work with adolescents with depression, especially where they may have a strong sense of hopelessness and self‐criticism. Moreover, the finding that adolescents experienced improvements in other domains despite a lack of symptom reduction highlights the need to review how treatment outcomes are currently defined. Integrating individual perspectives of therapy with quantitative outcome measures can provide a more nuanced insight of treatment effects. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
64. Adherence with mycophenolate mofetil in patients with autoimmune inflammatory rheumatic diseases in coventry: Signs of progress but challenges remain.
- Author
-
Chauhan, Aarti, Bunting, Helen, and Dubey, Shirish
- Subjects
- *
DRUG therapy for rheumatism , *ACADEMIC medical centers , *CHARITY , *MYCOPHENOLIC acid , *AUTOIMMUNE diseases , *RETROSPECTIVE studies , *TREATMENT effectiveness , *NATIONAL health services , *COMPARATIVE studies , *DESCRIPTIVE statistics , *IMMUNOSUPPRESSIVE agents , *DATA analysis software , *THERAPEUTICS - Abstract
Objective: The study investigated adherence with MMF treatment among patients attending rheumatology clinics at University Hospitals Coventry and Warwickshire NHS Trust (UHCW) with Autoimmune inflammatory rheumatic diseases (AIIRDs). Methods: This retrospective study collated hospital pharmacy data in patients who requested the prescription for MMF between January 2015 and December 2018. Clinical data were obtained from paper and electronic notes. Data were analysed using Microsoft Excel. Ethical approval was obtained through Coventry University. Results: We recruited 144 patients into this study with age range from 18 to 91 years, including 100 females and 44 males. There were 112 White patients, 22 of South Asian origin, 3 East Asian and 4 black patients. SLE (56), scleroderma (18), mixed connective tissue disease (15), myositis (13), vasculitis (13) were the commonest diagnoses. Overall adherence with Mycophenolate mofetil was 62%. The adherence rates were below 80% for all age groups with ∼60% of patients having adherence levels of >60%. Poor adherence with MMF correlated with 3‐fold increase in risk of flares compared to good adherence (p = 0.002). We also found a significant difference between Asian patients (mean adherence 47%) and White patients (mean adherence 65%, p < 0.001). Conclusion: Adherence with MMF has improved considerably compared to historical studies, although these remain suboptimal. Certain population groups such as young adults, elderly and Asian patients continue to have lower adherence and higher risk of flares. Strategies are needed to improve adherence levels overall and specifically in the high‐risk groups to reduce risk of flares and organ damage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
65. An intensive neurorehabilitation programme with sEMG biofeedback to improve swallowing in idiopathic Parkinson's disease (IPD): A feasibility study.
- Author
-
Battel, Irene and Walshe, Margaret
- Subjects
- *
THERAPEUTICS , *PILOT projects , *KRUSKAL-Wallis Test , *DEGLUTITION , *CONFIDENCE intervals , *ANALYSIS of variance , *RESEARCH methodology , *BIOFEEDBACK training , *DEGLUTITION disorders , *NEUROPLASTICITY , *PARKINSON'S disease , *QUALITY of life , *DESCRIPTIVE statistics , *INTRACLASS correlation , *ELECTROMYOGRAPHY , *DATA analysis software , *THEMATIC analysis , *LONGITUDINAL method , *MOTOR ability - Abstract
Background: Studies suggest swallow intervention programmes that incorporate visual biofeedback and motor programming principles can improve swallowing and quality of life for people with idiopathic Parkinson's disease (IPD) and dysphagia. Few studies have examined outcomes using instrumentation. Aims: Using fibreoptic endoscopic examination of swallowing (FEES), this study examines the effectiveness of a neurorehabilitation intervention involving biofeedback via surface electromyography (sEMG) to improve swallowing in people with IPD, and to explore the feasibility of the intervention approach. Methods & Procedures: We recruited 12 participants with IPD and dysphagia. A total of 10 completed the study. Intervention was delivered for 1 h per day, 5 days per week, for 4 weeks (20 h). Swallowing tasks using sEMG biofeedback incorporated principles of motor learning and neuroplasticity. Instrumental and non‐instrumental assessment, including quality‐of‐life measures carried out at four different time points (two pre‐treatment and two post‐treatment). The final assessment was at 3 months post‐intervention. Outcome & Results: Statistically significant improvement (p < 0.05) in oral intake methods (95% confidence interval (CI) = 4.70–5.50) and in pharyngeal residue from saliva (95% CI = 2.14–3.15) and solids (95% CI = 2.4–3.5) post‐intervention were confirmed using FEES with improvements at 3 months. The intervention protocol was well tolerated. Participants reported positive change in saliva control and duration of mealtimes as well as unanticipated improvements in voice and cognitive attention. Conclusions & Implications: An intensive neurorehabilitation with biofeedback shows positive effects in improving swallow function in IPD. This protocol is feasible with amendments to inform a larger clinical trial. What this paper adds: What is already known on the subject: Biofeedback has positive effects on increasing swallowing function and quality of life in people with IPD and dysphagia. sEMG is the most common method used to deliver swallowing biofeedback in this population. The quality of the evidence on the intervention, based on findings from a recent systematic review, is low. Included studies in this review were heterogeneous in terms of type and frequency of biofeedback, study design and outcome measures. The majority of outcome measures were subjective and higher quality studies to examine the efficacy of biofeedback using sEMG are needed. What this study adds: Recognizing the limitations of earlier studies, this within‐subject feasibility study examined the efficacy and effectiveness of an intensive biofeedback intervention using sEMG in a sample of people with dysphagia and IPD. Valid and reliable outcome measures were used and repeated after a 3‐month period. The feasibility of the methodological approach was also tested and a qualitative component was included in the study. Positive findings were evident. Qualitative information added new perspectives and provided direction for new outcomes to be included in future studies. This study helps to inform further research trials as well as clinical practice. Clinical implications of this study: This intensive intervention using principles of neuroplasticity and motor programming with sEMG biofeedback led not only to positive swallowing outcomes but also to unexpected benefits such as improved voice production and general attention skills. No adverse events were reported. Improvement in function was retained at 3 months post‐intervention. Despite the small sample size, participants described the benefits of the treatment, and enjoyed sEMG biofeedback tasks, especially using an sEMG game mode. This suggests that intensive biofeedback not only improved swallowing but also was acceptable to these participants. This intensive protocol has merit and is worth considering further in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
66. THE EARLY OPERATION FOR ACUTE SEVERE CHOLECYSTITIS: THE RIEDEL PAPER; AN INTRODUCTION AND TRANSLATION.
- Author
-
Scheele, S., Miller, D. A., and Hardy, K. J.
- Subjects
- *
CHOLECYSTECTOMY , *CHOLECYSTITIS , *THERAPEUTICS - Abstract
Background: For acute cholecystitis in the latter 19th century and early 20th century, the diagnosis was difficult and the management not defined. Methods and Results: Bernhard Riedel of Jena in Germany documented his patients, analysed his results, and described his method of cholecystectomy. Conclusions: Riedel advocated early operation for acute cholecystitis when the conditions were favourable, as for acute appendicitis. He stressed the importance of good lighting, an experienced surgeon and trained assistants. He advocated conservative treatment for minor cholecystitis (biliary colic) until the diagnosis was certain, followed by elective cholecystectomy to reduce the risk of subsequent acute cholecystitis or bile duct stones. Caution was advised when analysing previous statistics, to ensure appropriate patient comparison. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
67. Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis.
- Author
-
Bettinger, Dominik, Thimme, Robert, and Sturm, Lukas
- Subjects
- *
CIRRHOSIS of the liver , *THERAPEUTICS , *PATIENTS , *PANTOPRAZOLE , *H2 receptor antagonists - Abstract
LINKED CONTENT: This article is linked to Yoon et al paper. To view this article, visit https://doi.org/10.1111/apt.17909 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
68. Editor's Highlights — May 2024.
- Author
-
Kemény, Lajos
- Subjects
- *
HUMAN skin color , *THERAPEUTICS , *DIAGNOSIS , *HEALTH equity , *SKIN diseases - Abstract
Dermatological research and education have predominantly focused on lighter skin types in the past, leading to a significant gap in knowledge and understanding of conditions in darker skin types. This has contributed to disparities in the diagnosis and treatment of diseases in patients with skin of color. In the current issue of the Journal, we highlight four papers on the epidemiology and clinics of skin of color patients but also emphasize the importance of education and research in the dermatopathology of SOC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
69. Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B.
- Author
-
Wang, Jian, Fan, Tao, Zhang, Shaoqiu, Wu, Chao, and Huang, Rui
- Subjects
- *
KIDNEY physiology , *THERAPEUTICS - Abstract
LINKED CONTENT: This article is linked to Hong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17819 and https://doi.org/10.1111/apt.17937 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
70. In response to: Comparison of methods for the repair of acute tympanic membrane perforations: Silk patch vs. paper patch.
- Author
-
Lou, Zhengcai
- Subjects
- *
TYMPANIC membrane perforation , *THERAPEUTICS - Abstract
A letter to the editor is presented in response to the article "Comparison of Methods for the Repair of Acute Tympanic Membrane Perforations: Silk Patch vs Paper Patch" by J.Kim et al.
- Published
- 2016
- Full Text
- View/download PDF
71. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology.
- Author
-
Muraro, A., Roberts, G., Clark, A., Eigenmann, P. A., Halken, S., Lack, G., Moneret-Vautrin, A., Niggemann, B., and Ranc, F.
- Subjects
- *
ADRENALINE , *ANAPHYLAXIS , *FOOD allergy in children , *EMERGENCY management , *ALLERGY in children , *CLINICAL immunology , *EMERGENCY medical services , *THERAPEUTICS - Abstract
Anaphylaxis is a growing paediatric clinical emergency that is difficult to diagnose because a consensus definition was lacking until recently. Many European countries have no specific guidelines for anaphylaxis. This position paper prepared by the EAACI Taskforce on Anaphylaxis in Children aims to provide practical guidelines for managing anaphylaxis in childhood based on the limited evidence available. Intramuscular adrenaline is the acknowledged first-line therapy for anaphylaxis, in hospital and in the community, and should be given as soon as the condition is recognized. Additional therapies such as volume support, nebulized bronchodilators, antihistamines or corticosteroids are supplementary to adrenaline. There are no absolute contraindications to administering adrenaline in children. Allergy assessment is mandatory in all children with a history of anaphylaxis because it is essential to identify and avoid the allergen to prevent its recurrence. A tailored anaphylaxis management plan is needed, based on an individual risk assessment, which is influenced by the child’s previous allergic reactions, other medical conditions and social circumstances. Collaborative partnerships should be established, involving school staff, healthcare professionals and patients’ organizations. Absolute indications for prescribing self-injectable adrenaline are prior cardiorespiratory reactions, exercise-induced anaphylaxis, idiopathic anaphylaxis and persistent asthma with food allergy. Relative indications include peanut or tree nut allergy, reactions to small quantities of a given food, food allergy in teenagers and living far away from a medical facility. The creation of national and European databases is expected to generate better-quality data and help develop a stepwise approach for a better management of paediatric anaphylaxis. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
72. State‐of‐the‐art therapies for Rett syndrome.
- Author
-
Panayotis, Nicolas, Ehinger, Yann, Felix, Marie Solenne, and Roux, Jean‐Christophe
- Subjects
- *
RETT syndrome , *X chromosome , *RNA editing , *GENE therapy , *THERAPEUTICS , *Y chromosome , *NEURAL transmission - Abstract
Rett syndrome (RTT) is an X‐linked neurogenetic disorder caused by mutations of the MECP2 (methyl‐CpG‐binding protein 2) gene. Over two decades of work established MeCP2 as a protein with pivotal roles in the regulation of the epigenome, neuronal physiology, synaptic maintenance, and behaviour. Given the genetic aetiology of RTT and the proof of concept of its reversal in a mouse model, considerable efforts have been made to design therapeutic approaches to re‐express MeCP2. By being at the forefront of the development of innovative gene therapies, research on RTT is of paramount importance for the treatment of monogenic neurological diseases. Here we discuss the recent advances and challenges of promising genetic strategies for the treatment of RTT including gene replacement therapies, gene/RNA editing strategies, and reactivation of the silenced X chromosome. What this paper adds: Recent advances shed light on the promises of gene replacement therapy with new vectors designed to control the levels of MeCP2 expression.New developments in DNA/RNA editing approaches or reactivation of the silenced X chromosome open the possibility to re‐express the native MeCP2 locus at endogenous levels.Current strategies still face limitations in transduction efficiency and future work is needed to improve brain delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
73. Early recognition of SGCE‐myoclonus–dystonia in children.
- Author
-
Correa‐Vela, Marta, Carvalho, Joao, Ferrero‐Turrion, Julia, Cazurro‐Gutiérrez, Ana, Vanegas, Maria, Gonzalez, Victoria, Alvárez, Ramiro, Marcé‐Grau, Anna, Moreno, Antonio, Macaya‐Ruiz, Alfons, and Pérez‐Dueñas, Belén
- Subjects
- *
FOCAL dystonia , *THERAPEUTICS , *DYSTONIA - Abstract
Aim: To evaluate early dystonic features in children and adolescents with SGCE‐myoclonus–dystonia. Method: In this cross‐sectional study, 49 patients (26 females and 23 males) with SGCE‐myoclonus–dystonia (aged 15y 2mo, SD 12y) with childhood‐onset (2y 10mo, SD 1y 10mo) dystonia were examined using a standardized video recorded protocol. Dystonia was rated using the Writer's Cramp and Gait Dystonia Rating Scales. Disability and impairment for handwriting and walking were also rated. Results: Dystonia was present at rest (n=1), posture (n=12), and during specific motor tasks (n=45) such as writing (n=35), walking (n=23), and running (n=20). Most children reported disability while performing these tasks. Early dystonic patterns were identified for writer's cramp and gait dystonia, the latter named the 'circular shaking leg', 'dragging leg', and 'hobby‐horse gait' patterns. Sensory tricks were used by five and eight children to improve dystonia and myoclonus during writing and walking respectively. The rating scales accurately measured the severity of action dystonia and correlated with self‐reported disability. Interpretation: Children with SGCE‐myoclonus–dystonia show recognizable dystonic patterns and sensory tricks that may lead to an early diagnosis and timely therapeutic approach. Isolated writer's cramp is a key feature in childhood and should prompt SCGE analysis. The proposed action dystonia scales could be used to monitor disease course and response to treatment. What this paper adds: Most children with SGCE‐myoclonus–dystonia got writer's cramp and had walking and running dystonia.Writer's cramp was a key feature and should prompt SGCE genetic investigation.'Circular shaking leg', 'dragging leg', and 'hobby‐horse gait' were recognized as early gait patterns.Children used sensory tricks to improve myoclonus and dystonia, suggesting common pathophysiological mechanisms.Action dystonia rating scales are valid tools to assess severity in children. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
74. Preoperative medical treatments and surgical approaches for acromegaly: A systematic review.
- Author
-
Papaioannou, Christos and Druce, Maralyn
- Subjects
- *
ACROMEGALY , *THERAPEUTICS , *SOMATOSTATIN receptors , *ENDOSCOPIC surgery , *SOMATOTROPIN - Abstract
Objective: Acromegaly is a condition characterized by an overproduction of growth hormone which infers high morbidity and mortality if left untreated. The objective of this review is to analyse and appraise the current evidence for the generalized use of preoperative medications and the various surgical approaches as described in the literature. Design: A thorough search from MEDLINE via PubMed, EMBASE, and Cochrane Library has been performed which identified a total of 37 papers. Conclusion: The preoperative use of somatostatin receptor agonists (SAs) in acromegaly is a controversial topic with current guidelines suggesting against their generalized routine use. Most authors noticed an insignificant long‐term remission of acromegaly when given SAs compared with nil preoperative therapy, except for invasive macroadenomas as SAs have been found to reduce the tumour volume and aid towards the total resection of the adenoma. Furthermore, according to the evidence available, endoscopic transsphenoidal surgery is the optimum method for hypophysectomy in terms of its remission and safety profile. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
75. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
HORSE diseases , *SURGICAL complications , *POSTOPERATIVE care of animals , *UTERINE diseases , *TARSAL bones , *ANATOMY , *THERAPEUTICS - Abstract
The article offers updates on clinical records related to horses and their diseases. An analysis on the survival rates for mares and foals following uterine torsion is presented. A retrospective study on the factors relevant to post operative reflux and colic or jejunocecostomy is also discussed. An investigation on the relationship between the shape of the central and third tarsal bones is also explained.
- Published
- 2015
- Full Text
- View/download PDF
76. Using social media for patient and public involvement and engagement in health research: The process and impact of a closed Facebook group.
- Author
-
Fedorowicz, Sophia, Riley, Victoria, Cowap, Lisa, Ellis, Naomi J., Chambers, Ruth, Grogan, Sarah, Crone, Diane, Cottrell, Elizabeth, Clark‐Carter, David, Roberts, Lesley, and Gidlow, Christopher J.
- Subjects
- *
EXPERIMENTAL design , *THERAPEUTICS , *PATIENT participation , *SOCIAL media , *INTERVIEWING , *MEDICAL screening , *MEDICAL care research , *PRIMARY health care , *INFORMED consent (Medical law) , *NATIONAL health services , *COMMUNICATION , *DESCRIPTIVE statistics , *RISK management in business , *PUBLIC opinion , *VIDEO recording , *REFLECTION (Philosophy) - Abstract
Background: As part of a multifaceted approach to patient and public involvement and engagement (PPIE), alongside traditional methods, a closed Facebook group was established to facilitate PPIE feedback on various aspects of a project that used video‐recording to examine risk communication in NHS Health Checks between June 2017 and July 2019. Objective: To explore the process and impact of conducting PPIE through a closed Facebook group and to identify the associated benefits and challenges. Methods: Supported by reflections and information from project meetings used to document how this engagement informed the project, we describe the creation and maintenance of the Facebook Group and how feedback from the group members was obtained. Facebook data were used to investigate levels and types of engagement in the closed Facebook group. We reflect on the challenges of using this method of engaging the public in health research. Results: A total of 289 people joined the 'Risk Communication of Cardiovascular disease in NHS Health Checks' PPIE closed Facebook group. They provided feedback, which was used to inform aspects of the study, including participant‐facing documents, recruitment, camera position and how the methodology being used (video‐recorded Health Checks and follow‐up interviews) would be received by the public. Discussion: Using a closed Facebook group to facilitate PPIE offered a flexible approach for both researchers and participants, enabled a more inclusive method to PPIE (compared with traditional methods) and allowed rapid feedback. Challenges included maintaining the group, which was more labour intensive than anticipated and managing members' expectations. Suggestions for best practice include clear communication about the purpose of the group, assigning a group co‐ordinator to be the main point of contact for the group, and a research team who can dedicate the time necessary to maintain the group. Conclusion: The use of a closed Facebook group can facilitate effective PPIE. Its flexibility can be beneficial for researchers, patients and public who wish to engage in the research process. Dedicated time for sustained group engagement is important. Patient or Public Contribution: Patient representatives were engaged with the development of the research described in this paper and a patient representative reviewed the manuscript. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
77. Mesenchymal stroma/stem cells: Haematologists' friend or foe?
- Author
-
Nachmias, Boaz, Zimran, Eran, and Avni, Batia
- Subjects
- *
HEMATOPOIETIC stem cell transplantation , *STEM cells , *CLINICAL medicine , *THERAPEUTICS , *GRAFT versus host disease , *INTERSTITIAL cystitis - Abstract
Summary: Mesenchymal stromal cells (MSCs) are non‐haematopoietic cells found in fetal and adult organs, that play important roles in tissue repair, inflammation and immune modulation. MSCs residing in the bone marrow interact closely with haematopoietic cells and comprise an important component of the microenvironment supporting haematopoiesis, in both health and disease states. Since their identification in 1970, basic scientific and preclinical research efforts have shed light on the role of MSCs in the regulation of haematopoiesis and evoked interest in their clinical application in haematopoietic stem cell transplantation (HSCT) and malignant haematology. Over the last two decades, these research efforts have led to numerous clinical trials, which have established the safety of MSC therapy; however, the optimal mode of administration and the benefit remain inconclusive. In this paper, we will review the clinical experience with use of MSCs in HSCT for enhancement of engraftment, prevention and treatment of graft‐versus‐host disease and haemorrhagic cystitis. Then, we will discuss the contradictory evidence regarding tumour‐promoting versus tumour‐suppressing effects of MSCs in haematological malignancies, which may have relevance for future clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
78. From excitement to self‐doubt and insecurity: Speech–language pathologists' perceptions and experiences when treating children with a cleft palate.
- Author
-
Alighieri, Cassandra, Bettens, Kim, Verhaeghe, Sofie, and Van Lierde, Kristiane
- Subjects
- *
SPEECH therapy , *THERAPEUTICS , *CONFIDENCE , *TEACHING methods , *ATTITUDE (Psychology) , *SELF-perception , *RESEARCH methodology , *PROFESSIONAL employee training , *CLEFT palate , *INTERVIEWING , *FEAR , *CLEFT lip , *QUALITATIVE research , *FAMILY-centered care , *PSYCHOSOCIAL factors , *COMMUNITY health workers , *OUTCOME-based education , *DESCRIPTIVE statistics , *EMOTIONS , *THEMATIC analysis , *JUDGMENT sampling , *STATISTICAL sampling , *DATA analysis software , *PSYCHOLOGICAL adaptation , *SPEECH therapists , *TRUST - Abstract
Background: Speech disorders in children with a cleft palate with or without a cleft lip (CP±L) are complex given the magnitude of influencing factors. Providing intervention to eliminate these speech errors is often challenging. Speech–language pathologists (SLPs) might have negative perceptions of the treatment of children with a CP±L. Aims: To explore how community SLPs perceive and experience the provision of speech intervention to children with a CP±L. Methods & Procedures: A total of 18 female community SLPs, aged between 23 and 62 years, were included in this study. Semi‐structured interviews were conducted. The interviews were analysed using an inductive thematic approach aiming to identify themes driven by the data. Trustworthiness of the data was achieved by including researcher triangulation (involving three researchers with different research backgrounds) and deviant case analysis of two cases. Outcomes & Results: Initial responses demonstrated that the community SLPs were excited and enthusiastic to treat children with a CP±L. Expanding on these initial reports, however, they revealed that their excitement turned into professional self‐doubt and insecurity when confronted with the treatment challenges inherent with this population. To cope with this self‐doubt, they outlined several responsibilities for the cleft team SLPs. They expressed a strong desire to receive confirmation and approval on their treatment practices from more experienced SLPs (i.e., the cleft team SLPs). Their perceptions were dominated by a polarized thinking pattern. Treatment approaches were divided in categories as 'right' or 'wrong' and 'good' or 'bad'. Conclusions & Implications: The community SLPs are lacking professional confidence when treating children with a CP±L. They put themselves in a subordinate position towards the cleft team SLPs and expect the latter to provide ready‐made answers to problems and questions. This expectation can perhaps be explained by their fear of making mistakes during therapy preventing treatment progress. If they handle in accordance with the experts' advice, they cannot blame themselves in cases where no treatment progress is seen. Educational programmes need to pay more attention to gaining professional confidence (in the search for the most optimal treatment approach for each individual patient) rather than merely focusing on competency‐based learning tools. What this paper adds: What is already known on the subject: Speech disorders in children with a cleft palate with or without a cleft lip (CP±L) are complex given the magnitude of influencing factors. Providing intervention to eliminate these speech errors is often challenging. What this paper adds to existing knowledge: This study explored how community SLPs' perceive and experience the provision of speech intervention to children with a CP±L. The perceptions of community SLPs are dominated by a polarized thinking pattern. Treatment approaches are divided into categories as "right" or "wrong" and "good" or "bad". They lack professional confidence when they treat children with a CP±L. The community SLPs put themselves in a subordinate position towards the cleft team SLPs and expect the latter to provide ready‐made answers to problems and questions. What are the potential or actual clinical implications of this work?: Educational programs in speech‐language pathology need to pay more attention to gaining professional confidence rather than merely focusing on competency‐based learning tools. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
79. Free Papers.
- Subjects
- *
GASTROENTEROLOGY , *THERAPEUTICS , *ENDOSCOPY , *HELICOBACTER pylori - Abstract
Presents abstracts of studies related to gastroenterology and hepatology published in the October 2005 issue of "Journal of Gastroenterology and Hepatology." "A Comparative Study Using Propofol Alone Versus Propofol Combined Midazolam for Colonoscopy: Randomized Double-Blind Study," by Cheol Hee Park, Jong Hyeok Kim, Jae One Jung, Joon Ho Moon, Woon Geon Shin, Jong Pyo Kim, Kyoung Oh Kim, Taeho Hahn, Kyo-Sang Yoo, Sang Hoon Park, Soung Hoon Chang and Choong Kee Park; "Chromoendoscopy With Hematoxilin of Gastric Mucosa and Proliferating Cell Nuclear Antigen Expression," by Serguei Mouzyka, Michael Zakharash and Alexander Fedoseeva; "Diversity of Helicobacter Pylori Gene in Chinese With H. Pylori Infection," by Xuegong Fan, Guoling Hu and Zhang Zheng.
- Published
- 2005
- Full Text
- View/download PDF
80. Antimicrobial dosing in prolonged intermittent renal replacement therapy: a systematic review.
- Author
-
Rawlins, Matthew D. M., Misko, Jeanie, and Roberts, Jason A.
- Subjects
- *
THERAPEUTICS , *ONLINE information services , *MEROPENEM , *SYSTEMATIC reviews , *ANTI-infective agents , *RENAL replacement therapy , *VANCOMYCIN , *CRITICAL care medicine , *MEDLINE , *HEMODIALYSIS - Abstract
Aim: The research aim was to conduct a systematic review of the literature regarding the pharmacokinetics (PK) and dosing of antimicrobials in prolonged intermittent renal replacement therapy (PIRRT), a hybrid form of dialysis becoming increasingly utilised in critical care. Methods: A literature review was performed using PubMed from database inception to October 2020 according to the PRISMA guidelines. All papers published in English language were included in the review. Two researchers independently conducted literature searches, screened abstracts and full text and came to agreement as to which articles were suitable for inclusion before compiling the relevant data into a spreadsheet. The types of papers retrieved varied between case reports, single and multiple dose pharmacokinetic studies and Monte Carlo simulations. Results: A total of 149 articles were found in the initial literature review and via other sources. Of these papers, 50 articles were deemed eligible for inclusion. These studies included one to 34 patients. PIRRT settings varied between institutions, including filter surface area, duration of PIRRT and type of dialyser used. With the exception of vancomycin and meropenem, few antimicrobials had sufficient data available from which reasonable empiric dosing regimens can be recommended. Conclusion: There is limited data to guide dosing of antimicrobials during PIRRT. More studies are required to understand how dosing can be optimised in this population of critically ill patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
81. "We live in the moment"—Experiences of people with Intellectual Disabilities and Clinicians of Computer‐Assisted Mindfulness and Relaxation.
- Author
-
Clyne, Colette, Jackman, Catherine, Tully, Michael, Coyle, David, and O'Reilly, Gary
- Subjects
- *
MINDFULNESS , *THERAPEUTICS , *COMPUTERS in medicine , *ATTITUDES of medical personnel , *INTERVIEWING , *UNCERTAINTY , *COMMUNITY health services , *PATIENTS' attitudes , *EXPERIENCE , *DISABILITIES , *INTERPERSONAL relations , *PEOPLE with intellectual disabilities , *RELAXATION techniques , *VIDEO games , *THEMATIC analysis , *JUDGMENT sampling , *ADULTS , *MIDDLE age , *OLD age - Abstract
Accessible Summary: Sometimes people find it hard to notice what is going on in their mind, body and feelings. Mindfulness can help us with this. Some studies show that mindfulness might help people with intellectual disabilities.We asked people to play a mindfulness computer game to see whether it helped them to notice their mind, bodies and feelings more easily. People who work with people with intellectual disabilities helped to play the game too.We asked people what they thought about the game.People seem to enjoy playing the game and said it helped them be more mindful.We think that learning mindfulness in a computer game might be helpful for people with intellectual disabilities. Background: This paper evaluates the user experience of a newly developed mindfulness and relaxation game designed to teach mindfulness skills to people with intellectual disabilities. Computer‐assisted mindfulness programs have gained considerable attention among researchers in both adult and child populations. However, less is known about the experiences of people with intellectual disabilities who engage in computerised mindfulness programs. The present study aimed to explore the experiences of adults with intellectual disabilities and clinicians in using a computerised mindfulness and relaxation game. Method: Twelve adults (with a mild or moderate intellectual disability) and sixteen clinicians were individually interviewed. Thematic analysis was used to analyse and generate themes within the data. Findings: Three main themes with a number of subthemes were generated for people with intellectual disabilities including the following: (1) The Process of Mindful Island; (2) Fostering Relationships Through the Computer; and (3) The Impact of the Game. Three themes from clinician interviews were also generated including the following: (1) A Good Concept but More to Do; (2) Uncertainties Around Players' Understanding of Mindfulness; and (3) The Computer as a Tool to Build Relationships. The findings indicated that participants found the game an enjoyable experience and saw a number of benefits to engaging in it including perceived improved confidence and perceived reduction of worries. Conclusions: Mindfulness can be adapted to computer‐assisted technology for use among people with intellectual disabilities and may foster a number of benefits. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
82. Effect of CD38 on B‐cell function and its role in the diagnosis and treatment of B‐cell‐related diseases.
- Author
-
Zeng, Feng, Zhang, Jiani, Jin, Xi, Liao, Qianjin, Chen, Zhifang, Luo, Gengqiu, and Zhou, Yanhong
- Subjects
- *
B cells , *CD38 antigen , *THERAPEUTICS , *PROGNOSIS - Abstract
CD38 is a multifunctional receptor and enzyme present on the surface of B lymphocytes, which can induce B lymphocytes proliferation and apoptosis by crosslinking related cytokines to affect the function of B cells, thus affecting immune regulation in humans and promoting tumorigenesis. The level of CD38 expression in B cells has become an important factor in the clinical diagnosis, treatment, and prognosis of malignant tumors and other related diseases. Therefore, studying the relationship between CD38 expression on the surface of B cells and the occurrence of the disease is of great significance for elucidating its association with disease pathogenesis and the clinical targeted therapy. In this paper, we review the effects of CD38 on B‐cell activation, proliferation, and differentiation, and elaborate the functional role and mechanism of CD38 expression on B cells. We also summarize the relationship between the level of CD38 expression on the surface of B cells and the diagnosis, treatment, and prognosis of various diseases, as well as the potential use of targeted CD38 treatment for related diseases. This will provide an important theoretical basis for the scientific research and clinical diagnosis and treatment of B‐cell‐related diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
83. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
TREATMENT of eczema , *INSECT bites & stings , *DIAGNOSIS , *PROGNOSTIC tests , *SEPSIS , *ALTERNATIVE medicine , *THERAPEUTICS , *HORSE diseases - Abstract
The article discusses the highlights on the study for treatment of summer eczema or insect bite hypersensitivity which can cause skin lesions and pruritus in horse and suggests that autologous serums as an alternative treatment. It highlights on the study which aims to identify the factors associated with prognostic indicators for synovial sepsis. It also notes on the treatment of endotoxaemia in neonatal foals for fourteen healthy neonatal foals.
- Published
- 2013
- Full Text
- View/download PDF
84. Withdrawal of intensive care during times of severe scarcity: Triage during a pandemic only upon arrival or with the inclusion of patients who are already under treatment?
- Author
-
Dufner, Annette
- Subjects
- *
ATTITUDE (Psychology) , *BIOETHICS , *HEALTH care rationing , *HEALTH services accessibility , *HOSPITAL admission & discharge , *INTENSIVE care units , *MEDICAL care , *PATIENTS , *SURVIVAL , *THERAPEUTICS , *MEDICAL triage , *UNCERTAINTY , *REFUSAL to treat , *PASSIVE euthanasia , *COVID-19 pandemic - Abstract
Many countries have adopted new triage recommendations for use in the event that intensive care beds become scarce during the COVID‐19 pandemic. In addition to establishing the exact criteria regarding whether treatment for a newly arriving patient shows a sufficient likelihood of success, it is also necessary to ask whether patients already undergoing treatment whose prospects are low should be moved into palliative care if new patients with better prospects arrive. This question has led to divergent ethical guidelines. This paper explores the distinction between withholding and withdrawing medical treatment during times of scarcity. As a first central point, the paper argues that a revival of the ethical distinction between doing and allowing would have a revisionary impact on cases of voluntary treatment withdrawal. A second systematic focus lies in the concern that withdrawal due to scarcity might be considered a physical transgression and therefore more problematic than not treating someone in the first place. In light of the persistent disagreement, especially concerning the second issue, the paper concludes with two pragmatic proposals for how to handle the ethical uncertainty: (1) triage protocols should explicitly require that intensive care attempts are designed as time‐limited trials based on specified treatment goals, and this intent should be documented very clearly at the beginning of each treatment; and (2) lower survival prospects can be accepted for treatments that have already begun, compared with the respective triage rules for the initial access of patients to intensive care. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
85. What are the implications of climate change for speech and language therapists?
- Author
-
Sherratt, Sue
- Subjects
- *
TREATMENT of communicative disorders , *CLIMATE change , *COMMUNICATIVE disorders , *DEGLUTITION , *DEGLUTITION disorders , *ENVIRONMENTAL health , *GREENHOUSE effect , *HEALTH promotion , *HEALTH services accessibility , *MEDICAL practice , *PATIENT advocacy , *PROFESSIONAL employee training , *SPEECH therapy , *THERAPEUTICS , *WORLD health , *OCCUPATIONAL roles , *SOCIOECONOMIC factors , *DISEASE incidence , *MIDDLE-income countries , *LOW-income countries - Abstract
Background: The emerging global issue of climate change has large‐scale effects on health and well‐being, including communication disorders. The broad range of the speech and language therapy profession's scope of practice incorporates prevention, advocacy and equality in service delivery. These act as a springboard for involvement in climate change and health. Aims: This is an appeal to speech and language therapists (SLTs) to focus and take action on this issue and its considerable effects on communication and swallowing disorders. Methods & Procedures: This article discusses the importance of taking a public health position on prevention and equality of services to manage environmental determinants of communication and swallowing disorders. It also describes the extent to which climate change affects these disorders and exacerbates the inequality of healthcare services in low‐ and middle‐income countries. Main Contribution: Five strategies are provided for action on fulfilling therapists' roles in reducing the incidence, development and exacerbation of climate‐related communication and swallowing disorders, as well as the role of SLTs in acting as advocates. The case is made for expanding the scope of services to focus on prevention and service equality so as to best meet the needs of the wider community. Conclusions & Implications: Despite other challenges currently facing SLTs, climate change and its increasing effects on communication disorders and dysphagia is difficult to ignore. SLTs owe it to their clients, the wider community, low‐ and middle‐income countries, the economy, and the future to take action. What this paper addsWhat is already known on the subjectMultiple studies published in peer‐reviewed scientific journals show that climate change is extremely likely to be due to human activities. The global effects will be higher temperatures, changes in precipitation, more droughts and heatwaves, stronger and more intense hurricanes, and a rising sea level which directly threaten the health of entire populations. Other health professions are beginning to take climate change into account in training and practice.What this paper adds to existing knowledgeMany disorders of communication and swallowing are caused or exacerbated by the effects of climate change. Increasing temperatures, extremes of precipitation, population displacement and air pollution contribute to cardiovascular and cerebrovascular events, respiratory disease, malnutrition, premature birth, air‐ and water‐borne diseases, and mental illness. These may affect the communication and swallowing abilities across the lifespan, but particularly those of children and older adults.What are the potential or actual clinical implications of this work?SLTs' roles in prevention, advocacy and education act as a starting point for involvement in climate change and health. Three practical strategies for action include educating SLTs and other health professionals on climate change and its effects on communication and swallowing, promoting awareness with clients and their families, and gathering and disseminating reliable data. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
86. SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention.
- Author
-
Ward, Thomas, Hardy, Amy, Holm, Rebecca, Collett, Nicola, Rus‐Calafell, Mar, Sacadura, Catarina, McGourty, Alison, Vella, Claire, East, Anna, Rea, Michaela, Harding, Helen, Emsley, Richard, Greenwood, Kathryn, Freeman, Daniel, Fowler, David, Kuipers, Elizabeth, Bebbington, Paul, and Garety, Philippa
- Subjects
- *
UNIVERSAL design , *MINDFULNESS , *THOUGHT & thinking , *THERAPEUTICS , *COMPUTERS in medicine , *PSYCHOSES , *USER interfaces , *APPLICATION software , *SELF-perception , *RESEARCH methodology , *DIGITAL technology , *FEAR , *PATIENT-centered care , *MEDICAL care , *HARM reduction , *DESCRIPTIVE statistics , *WORRY , *ANXIETY , *PSYCHOLOGICAL adaptation , *COGNITIVE therapy , *TELEMEDICINE , *PARANOIA , *WORLD Wide Web , *PSYCHOLOGICAL stress - Abstract
Objectives: SlowMo therapy is a pioneering blended digital therapy for paranoia, augmenting face‐to‐face therapy with an interactive 'webapp' and a mobile app. A recent large‐scale trial demonstrated small–moderate effects on paranoia alongside improvements in self‐esteem, worry, well‐being and quality of life. This paper provides a comprehensive account of therapy personalisation within this targeted approach. Design: Case examples illustrate therapy delivery and descriptive data are presented on personalised thought content. Method: Thought content was extracted from the webapp (n = 140 participants) and coded using newly devised categories: Worries: (1) Persecutory, (2) Negative social evaluation, (3) Negative self‐concept, (4) Loss/life stresses, (5) Sensory‐perceptual experiences and (6) Health anxieties. Safer thoughts: (1) Safer alternative (specific alternatives to worries), (2) Second‐wave (generalised) coping, (3) Positive self‐concept, (4) Positive activities and (5) Third‐wave (mindfulness‐based) coping. Data on therapy fidelity are also presented. Results: Worries: 'Persecutory' (92.9% of people) and 'Negative social evaluation' (74.3%) were most common. 'General worries/ life stresses' (31.4%) and 'Negative self‐concept' (22.1%) were present in a significant minority; 'Health anxieties' (10%) and 'Sensory‐perceptual' (10%) were less common. Safer thoughts: 'Second‐wave (general) coping' (85%), 'Safer alternatives' (76.4%), 'Positive self‐concept' (65.7%) and 'Positive activities' (64.3%) were common with 'Third‐wave' (mindfulness) coping observed for 30%. Fidelity: Only three therapy withdrawals were therapy related. Session adherence was excellent (mean = 15.2/16; SD = 0.9). Behavioural work was conducted with 71% of people (119/168). Conclusion: SlowMo therapy delivers a targeted yet personalised approach. Potential mechanisms of action extend beyond reasoning. Implications for cognitive models of paranoia and causal interventionist approaches are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
87. Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature.
- Author
-
Atwood, Daniel, Nelson, Amanda, Rosen, Rachel, Esteso, Paul, Visner, Gary, and Midyat, Levent
- Subjects
- *
TRANSPLANTATION of organs, tissues, etc. , *HEART transplantation , *LUNG transplantation , *LITERATURE reviews , *THERAPEUTICS - Abstract
Pneumatosis intestinalis (PI) is a rare complication after thoracic organ transplantation. There are several theories for explaining the pathophysiology of this disease. In this paper, we highlight three cases of PI in a single pediatric center, one after lung transplantation and two after heart transplantation. Although the presentations differed, all cases improved with non‐surgical therapies. There are not many articles in the pediatric literature about post‐transplantation PI, and there are still many questions regarding the incidence, etiology, and treatment for this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
88. Advances in the Stimuli‐Responsive Injectable Hydrogel for Controlled Release of Drugs.
- Author
-
Mo, Chunxiang, Luo, Rui, and Chen, Yuping
- Subjects
- *
HYDROGELS , *CONTROLLED release drugs , *REACTIVE oxygen species , *THERAPEUTICS , *GELATION , *TREATMENT effectiveness - Abstract
The stimuli‐responsiveness of injectable hydrogel has been drastically developed for the controlled release of drugs and has achieved encouraging curative effects in a variety of diseases including wounds, cardiovascular diseases, and tumors. The gelation, swelling, and degradation of such hydrogels respond to endogenous biochemical factors (such as pH, reactive oxygen species, glutathione, enzymes, glucose) and/or to exogenous physical stimulations (like light, magnetism, electricity, and ultrasound), thereby accurately releasing loaded drugs in response to specifically pathological status and as desired for treatment plan, and thus improving therapeutic efficacy effectively. This paper gives a detailed introduction of recent progresses in responsive injectable hydrogels and focuses on the design strategy of various stimuli‐sensitivities and their resultant alteration of gel dissociation and drug liberation behavior. Their application in disease treatment is also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
89. Nursing research: a position paper.
- Author
-
Greenwood J
- Subjects
- *
NURSING research , *SICK people , *MEDICINE , *MEDICAL care , *PUBLIC health , *THERAPEUTICS - Published
- 1984
- Full Text
- View/download PDF
90. Highlights of recent clinically relevant papers.
- Author
-
Wright, S.
- Subjects
- *
VETERINARY medicine , *ETHANOL , *OSTEOARTHRITIS treatment , *ULTRASONIC imaging , *THERAPEUTICS ,ABSTRACTS - Abstract
The article presents abstracts of articles on equine veterinary topics including "Ethanol treatment for distal tarsal joint osteoarthritis," by L. Lamas and colleagues, "Angular limb deformities of the distal radius," by E. R. Carlson and colleagues, and "How precise are ultrasonographic measurements?," by J. M. Zauscher and colleagues.
- Published
- 2012
- Full Text
- View/download PDF
91. Issue Information - Papers to be published in forthcoming issues.
- Subjects
- *
IMATINIB , *MYELOFIBROSIS , *THERAPEUTICS ,SIDE effects of thalidomide - Abstract
The article lists the studies to be published in forthcoming issues on topics including bowel perforation while on thalidomide treatment, imatinib treatment for leukemia patients, and ruxolitinib for myelofibrosis treatment.
- Published
- 2016
- Full Text
- View/download PDF
92. Analysis of Recent Papers in Hypertension.
- Author
-
Bloch, Michael J. and Basile, Jan
- Subjects
- *
PROGESTATIONAL hormones , *THERAPEUTICS , *HYPERTENSION , *HORMONE therapy for menopause , *HORMONE therapy - Abstract
Analyzes a study on the significance of the progestin called drospirenone in reducing blood pressure when combined with estradiol in postmenopausal women with stage 1 hypertension. Information on drospirenone; Benefits of postmenopausal hormone therapy; Methods used in the study and its results.
- Published
- 2006
93. Selected Papers: Childhood Epilepsies.
- Author
-
Inutsuka, Miki, Ohtsuka, Yoko, Nakano, Kousuke, Hattori, Junri, Kobayashi, Katsuhiro, and Oka, Eiji
- Subjects
- *
EPILEPSY , *THERAPEUTICS , *SYNTHETIC drugs , *PATIENTS , *VALPROIC acid , *DIAZEPAM - Abstract
Treatment of Epilepsy with Electrical Status Epilepticus During Slow-Wave Sleep and Factors Related to the Response to Treatment.Purpose:To elucidate the effect of treatment of epilepsy with electrical status epilepticus during slow sleep (ESES) and factors related to the response to treatment.Methods:We studied 26 patients with ESES who were admitted to Okayama University Hospital (age range, 2y0m to 9y7m). Patients were treated with one or more of the following therapies: (a) high-dose valproate (VPA) therapy (plasma level,>100μg/ml), (b) a combination therapy of VPA and ethosuximide (ESM), (c) a short cycle of high-dose diazepam (DZP; 0.54–1 mg/kg/day, orally or intrarectally for 6–14 days), and (d) synthetic adrenocorticotropic hormone (ACTH) therapy (Cortrosyn-Z; 0.01–0.036 mg/kg/day, intramuscularly, for 11–43 days). Basically, we started treatment with high-dose VPA therapy. When this failed or yielded adverse side effects, we tried the combination therapy of VPA and ESM. When both were unsuccessful, we tried a short cycle of high-dose DZP or synthetic ACTH therapy. All patients were followed up for≥2 years. We also investigated response patterns to treatments and mental outcome in each patient.Results:Treatment effects: Regarding the initial effects, treatment was defined as effective when continuous spike–waves during slow-wave sleep (CSWSs) were suppressed (≥1 month with markedly decreased or no diffuse spike-waves during slow-wave sleep). In terms of initial effect, high-dose VPA was effective in 12 (50%) of 24 trials; combination therapy with VPA and ESM in six (43%) of 14 trials; a short cycle of high-dose DZP, in six (75%) of eight trials; and synthetic ACTH, in three (43%) of seven trials. However, CSWSs recurred within 1 year of treatment in two patients treated with high-dose VPA, in four treated with a short cycle of high-dose DZP, and in all three treated with synthetic ACTH. Response patterns and mental outcomes: Subjects were divided into two groups: 15 patients with favorable EEG response to the initial treatment maintained throughout the clinical course (group A), and 11 patients with no favorable EEG response to the initial treatment, or deterioration after an initial favorable response (group B). All patients except one in group A were treated with high-dose VPA or the combination therapy of VPA and ESM or both. All patients except two in group B were treated with a short cycle of high-dose DZP or synthetic ACTH after the failure of high-dose VPA or both or the combination therapy of VPA and ESM or both. Comparing these two groups, ages at onset of ESES were significantly lower in group B (p= 0.0009). Organic brain lesions such as brain malformations were seen more often in group B. Mental deterioration after the onset of ESES was observed significantly more often in group B (p= 0.037). Regarding mental outcome, patients with normal mentality or slight mental retardation predominated in group A, whereas those with severe mental retardation were found only in group B.Conclusions:Remission of ESES was achieved in approximately half of the patients treated with high-dose VPA therapy or combination therapy with VPA and ESM or both. Even when these treatments were ineffective, a short cycle of high-dose DZP or synthetic ACTH therapy was effective in most cases. However, the effects of the latter two treatments were only temporary. Group B was characterized by early-onset patients associated with organic brain lesions. These patients responded poorly to treatment and consequently had mental deterioration and poor mental outcomes. Thus response to ESES treatment may be related to the underlying organic brain lesion(s). To prevent poor mental outcome, we believe that it is critical to achieve remission as early as possible by using intensive treatment. An Investigation of Growth and Growth Disorders in School-Aged Patients with Post-West Syndrome.Purpose:To contribute to improved quality of life (QOL) for school-aged children with epilepsy, we investigated growth and growth disorders in patients with the post-West syndrome, who may be at greater risk for short stature.Methods:The 26 school-aged epilepsy patients with post-West syndrome (p-WS) were studied after informed consent was obtained from the parents. The patients consisted of seven who had cryptogenic WS[M/F= 3:4; mean age, 8 years; without cerebral palsy and nutritional problem (six of seven cases, 85.7%)] and 19 who had symptomatic WS[M/F= 11:8; mean age, 8.3 years; with cerebral palsy and required tube feeding (10 of 19 cases, 52.6%)]. The cross-sectional height SD score (HSDS), ratio of bone age to chronologic age (BA/CA), serum insulin-like growth factor (IGF-1) and other biochemical markers (serum ALP, Ca, IP, total protein and total albumin) were measured. The differences between the p-WS patients, divided into cryptogenic WS and symptomatic WS, and age-matched children with epilepsy were compared. The correlation between growth disorders and some clinical factors was investigated.Results:(a) The mean HSDS and the rate of short stature (HSDS≤−2.0 SD) in the p-WS patients were−1.89 SD (−5.94 to+0.63 SD) and 11 of 26 cases (42.3%), respectively. Obvious growth retardation without bone maturational delay (BA/CA: 0.88) was noticed in the p-WS patients compared with 56 age-matched epilepsy patients we reported previously (mean HSDS,−0.75 SD; HSDS≤−2.0 SD; 10 of 56 cases, 17.9%). Especially the symptomatic WS group showed markedly shorter stature (mean HSDS,−2.34 SD) and lower serum IGF-1 and ALP levels (mean, 110 ng/ml and 465 IU/L, respectively) compared with the cryptogenic WS group, who showed growth similar to that of age-matched epilepsy controls. (b) Markedly short stature (HSDS≤−2.0 SD) and abnormally low serum IGF-1 levels (≤−2.0 SD) were observed most frequently in the patients with cerebral palsy and feeding problems (eight of 11 cases, 72.7%, and five of 11 cases, 45.5%, respectively), followed by patients with prenatal etiology and those with poor seizure prognosis. However, the therapeutic regimens and the EEG findings showed no correlation with the growth disorders (3). Severely short stature (HSDS≤−3 SD, six of 26 cases, 23.1%) was noticed exclusively in the symptomatic WS group with cerebral palsy and feeding difficulties, as a result of an almost bedridden state and malnutrition.Conclusions:We have great concerns about the QOL of school-aged children with epilepsy and previously reported their growth and growth disorders as a part of the studies to improve their QOL. In this study, we investigated the growth in p-WS patients who may be at greater risk for short stature. Marked growth retardation was observed in the p-WS patients, especially in those with symptomatic WS, compared with age-matched controls and cryptogenic WS. Definite short stature (HSDS≤−2 SD) and low IGF-1 levels were observed mostly in patients with the complications of cerebral palsy requiring tube feeding, regardless of their EEGs and therapeutic regimens. It is particularly noteworthy that markedly short stature (HSDS≤−3 SD, six of 26, 23.1%) was observed exclusively in the symptomatic WS cases with cerebral palsy and feeding difficulties. The growth disorders may be a result of severe motor disturbances, leading to an almost bedridden state, and low IGF-1 levels may be due to malnutrition. Few reports exist of growth disorders in school-aged epilepsy patients, especially in the p-WS patients. As a base for comprehensive medicine for children with epilepsy to improve QOL, further accumulation of findings on growth and growth disorders is required. Long-Term Prognosis of Infantile Spasms (ISs): Late Relapses of Other Seizures After the Last IS.Purpose:The timing of discontinuation of drug treatment should vary with individual epileptic syndromes. Epilepsies with early onset probably deserve protracted periods of treatment (>5 years) because they are usually severe. In such cases, late relapses of other seizures are not uncommon, whereas precise studies are not known. In this study, we analyzed the long-term prognosis of infantile spasms (ISs) with special reference to late relapses.Methods:Between1969 to 2001, 52 children with ISs were treated at our facilities. Among them, 35 patients (19 boys and 16 girls) who had been followed up for>5 years were analyzed in this study. The follow-up period ranged from 5 to 33 years, with an average of 15.3 years. Adrenocorticotropic hormone (ACTH) therapy was used in 26 cases. Patients were divided into three groups according to the seizure status after the last IS; group I (G-I), eight seizure-free cases after the last IS; group II (G-II), eight cases with a seizure-free period of>5 years; and group III (G-III): 19 cases who continued to have seizures or relapsed within 5 years.Results:The classification of ISs and the mental status of 35 patients were analyzed in each group. Although the ratio of cryptogenic to symptomatic cases was the same in G-I (4:4) and G-II (4:4), G-III included many symptomatic cases (3:16). Mental status was assessed by the ratio of normal mentality/mild delay/moderate delay/severe delay. It was better in G-I (2:4:2:0) than in G-II (1:2:5:0), whereas G-III had many cases with severe mental delay (0:1:5:13). Next, we analyzed the forms of other seizures after the last IS in each group. The most common form of other seizures was partial seizures in G-II (seven of eight cases), often with secondary generalization (five of seven cases), and Lennox–Gastaut syndrome in G-III (nine of 19 cases). Then late relapses of other seizures were analyzed in G-II that had eight patients with seizure-free periods for>5 years (>10 years for five of eight patients, and 5–10 years for the remaining three). Ages at relapses after the last IS ranged from 5 years 11 months to 19 years 2 month, with an average of 11 years 11 months). The drug-free period of these eight cases ranged from 0 to 7 years, with an average of 2 years 6 months. Four patients were drug free for several years. For late relapses, focal paroxysmal discharges were found in the EEGs of seven patients. Focal discharges were most commonly found in the temporal region (five cases), followed by the frontal (one case) and the occipital region (one case). The prognosis of other seizures after a long seizure-free period was good in six cases, whereas in the other two patients, seizures were refractory to treatment. Refractory cases include cryptogenic as well as symptomatic cases.Discussion:Among 35 patients with ISs followed up for>5 years, eight (23%) cases had late relapses>5 years after the last IS. Five of eight cases had seizure-free periods of>10 years, and four cases had drug-free periods of several years. Four of eight cases were cryptogenic. From these observations, long-term follow-up is necessary, even in cryptogenic cases that have been seizure free and drug free for long periods. Other seizures that occurred after long seizure-free periods were mostly partial seizures with secondary generalization. These seizures, however, were fortunately not so therapy resistant. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
94. People with intellectual disabilities and their experience of medication: A narrative literature review.
- Author
-
MacLeod, Joan and MacLure, Katie
- Subjects
- *
ATTITUDE (Psychology) , *DRUGS , *DRUG administration , *PEOPLE with intellectual disabilities , *THERAPEUTICS , *SYSTEMATIC reviews , *POLYPHARMACY , *PATIENTS' attitudes - Abstract
Background: People with intellectual disabilities are known to have increased medical needs and are prescribed more medication than the general population. Understanding the reality of incorporating medication into their lives would help healthcare professionals provide care in more meaningful and personalised ways. Aim: A narrative review of the current literature relating to people with intellectual disabilities and their experience of medication/pharmaceutical care. Method: Electronic databases were searched for articles relating to intellectual disabilities and medication administration or pharmaceutical care. Other relevant papers identified from included article reference lists were also identified. A narrative literature was undertaken due to the heterogeneity of the identified papers. Results: A total of 29 studies from the literature searches were included alongside other relevant papers. Conclusions: The published literature noted some aspects of the medication‐related experiences of people with intellectual disabilities. However, a greater understanding of medication‐related experiences is still required. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
95. Survival outcomes of hepatic resections in Bismuth‐Corlette type IV cholangiocarcinoma.
- Author
-
Ku, Dominic, Tang, Reuben, Pang, Tony, Pleass, Henry, Richardson, Arthur, Yuen, Lawrence, and Lam, Vincent
- Subjects
- *
SURGICAL excision , *CLINICAL trial registries , *THERAPEUTICS , *OPERATIVE surgery , *RADIOEMBOLIZATION , *CHOLANGIOCARCINOMA , *SURGICAL blood loss - Abstract
Background: Surgical resection for Bismuth‐Corlette type IV (BC‐IV) hilar cholangiocarcinomas, also termed Klatskin tumours are technically challenging and were once considered unresectable tumours. Following advances in hepatobiliary imaging and surgical techniques, emerging evidence suggests that surgical resection is a viable avenue for long‐term survival. We aimed to identify factors affecting survival outcomes of hepatic resections for BC‐IV cholangiocarcinomas. Method: A systematic review was performed across multiple databases and several clinical trial registries. Two reviewers independently screened and selected papers that contained survival data on BC‐IV cholangiocarcinoma after hepatic resections. Results: Of 13 499 papers from our search result, 21 papers satisfied the inclusion criteria. The median post‐operative survival was 30.8 months. The average 1‐ and 5‐year post‐operative survivals were 61.6 and 33.3%, respectively. Predictors of long‐term survival included achievement of R0 margins, minimisation of operative time and reduction intra‐operative blood loss. Conclusion: Our analysis demonstrates improving post‐operative outcomes and survival in surgical resection of BC‐IV cholangiocarcinoma and suggests that radical surgical resection is a valid treatment option for the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
96. Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults—authors' reply.
- Author
-
Wu, Xiaoli and Peng, Songxu
- Subjects
- *
CHRONIC hepatitis B , *HEPATITIS B , *THERAPEUTICS , *AUTHORS - Abstract
LINKED CONTENT: This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17679 [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
97. Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults.
- Author
-
Choi, Won‐Mook and Lim, Young‐Suk
- Subjects
- *
CHRONIC hepatitis B , *HEPATITIS B , *THERAPEUTICS - Abstract
LINKED CONTENT: This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17685 [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
98. Highlights of Papers in the Clinical Investigations Section.
- Subjects
- *
CLINICAL trials , *THERAPEUTICS , *MEDICAL care - Abstract
Presents developments related to clinical trials of various diseases and their treatment. Role of delirium in the mortality rate of hospitalized older adults.
- Published
- 2003
- Full Text
- View/download PDF
99. Speech and language therapy service provision in spinal injury units compared to major trauma centres in England: Are services matched?
- Author
-
McRae, Jackie, Hayton, Jennifer, and Smith, Christina
- Subjects
- *
THERAPEUTICS , *LENGTH of stay in hospitals , *TEAMS in the workplace , *SPINAL cord injuries , *SPEECH therapy , *DEGLUTITION , *TRAUMA centers , *COMMUNICATIVE competence , *DEGLUTITION disorders , *SPEECH evaluation , *COMPARATIVE studies , *CRITICAL care medicine , *RESEARCH funding , *DESCRIPTIVE statistics , *QUESTIONNAIRES , *EMPLOYEES' workload , *PHYSICIAN practice patterns , *WORKING hours - Abstract
Background: National UK guidance makes recommendations for speech and language therapy staffing levels in critical care and rehabilitation settings. Traumatic spinal cord injury patients often require admission primarily to critical care services within a major trauma centre prior to transfer to a specialist spinal injury unit but may not receive similar levels of care. Dysphagia and communication difficulties are recognised features of cervical spinal cord injury; however, little is known about access to speech and language therapy services to provide rehabilitation and improve outcomes. Aims: The aim of this study was to compare the workforce and clinical practices of speech and language therapy services in eight spinal injury units and four major trauma centres in England through an online survey. Methods & Procedures: An online survey was created with 26 multiple‐choice questions across seven sub‐sections, with options for free‐text comments. These were sent to a named speech and language therapy contact at each of the specified units. Responses were uploaded into Excel for analyses, which included descriptive statistics and analysis of themes. Outcomes & Results: Responses were received from 92% (11/12) speech and language therapy services invited, which included seven out of eight spinal injury units and all four major trauma centres. No units met national staffing recommendations. Staff in spinal injury units provided an average of 27 h per week input to the unit compared to 80 h in a major trauma centre. Despite caseload variations, speech and language range of therapy involvement and prioritisation process were equivalent. Access to instrumental assessment varied, with less use of Fibreoptic Endoscopic Evaluation of Swallowing in spinal injury units despite its clinical value to the spinal cord injury caseload. Conclusions & Implications: Speech and language therapy services delivering post‐acute and long‐term rehabilitation to spinal cord injury patients are limited by their resources and capacity, which restricts the level of therapy delivered to patients. This may have an impact on clinical outcomes for communication and swallowing impairments. Further evidence is needed of the interventions delivered by speech and language therapists and outcomes will be beneficial alongside benchmarking similar services. What this paper adds: What is already known on this subject: In England, people who sustain a spinal cord injury are admitted to a major trauma centre prior to transfer to a specialist spinal injury unit. Dysphagia and communication impairments are recognised as a complication of cervical spinal cord injury and benefit from speech and language therapy intervention. National recommendations exist for staffing levels, expertise and competencies for speech and language therapists working in critical care and rehabilitation units. What this study adds: This study identified variations in the levels of speech and language therapy staffing, seniority, service delivery and access to instrumental assessments for dysphagia between major trauma centres and spinal injury units. None of the services complied with national staffing recommendations. Clinical implications of this study: Speech and language therapy services in spinal injury units are often available part‐time or have limited access to diagnostic tools which limits the range and intensity of rehabilitation input available. This has clinical implications for outcomes for swallowing and communication as well as long‐term consequences for integrating back into community. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
100. Estimands for overall survival in clinical trials with treatment switching in oncology.
- Author
-
Manitz, Juliane, Kan‐Dobrosky, Natalia, Buchner, Hannes, Casadebaig, Marie‐Laure, Degtyarev, Evgeny, Dey, Jyotirmoy, Haddad, Vincent, Jie, Fei, Martin, Emily, Mo, Mindy, Rufibach, Kaspar, Shentu, Yue, Stalbovskaya, Viktoriya, Tang, Rui, Yung, Godwin, and Zhou, Jiangxiu
- Subjects
- *
OVERALL survival , *CLINICAL trials , *ONCOLOGY , *SURVIVAL analysis (Biometry) , *THERAPEUTICS - Abstract
An addendum of the ICH E9 guideline on Statistical Principles for Clinical Trials was released in November 2019 introducing the estimand framework. This new framework aims to align trial objectives and statistical analyses by requiring a precise definition of the inferential quantity of interest, that is, the estimand. This definition explicitly accounts for intercurrent events, such as switching to new anticancer therapies for the analysis of overall survival (OS), the gold standard in oncology. Traditionally, OS in confirmatory studies is analyzed using the intention‐to‐treat (ITT) approach comparing treatment groups as they were initially randomized regardless of whether treatment switching occurred and regardless of any subsequent therapy (treatment‐policy strategy). Regulatory authorities and other stakeholders often consider ITT results as most relevant. However, the respective estimand only yields a clinically meaningful comparison of two treatment arms if subsequent therapies are already approved and reflect clinical practice. We illustrate different scenarios where subsequent therapies are not yet approved drugs and thus do not reflect clinical practice. In such situations the hypothetical strategy could be more meaningful from patient's and prescriber's perspective. The cross‐industry Oncology Estimand Working Group (www.oncoestimand.org) was initiated to foster a common understanding and consistent implementation of the estimand framework in oncology clinical trials. This paper summarizes the group's recommendations for appropriate estimands in the presence of treatment switching, one of the key intercurrent events in oncology clinical trials. We also discuss how different choices of estimands may impact study design, data collection, trial conduct, analysis, and interpretation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.